Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/06/2003US20030207358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207357 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207356 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207355 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207354 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207353 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207352 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207351 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207350 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207349 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207348 For predetermination, diagnosis, and therapy for related disorders
11/06/2003US20030207347 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation
11/06/2003US20030207346 Method for making multispecific antibodies having heteromultimeric and common components
11/06/2003US20030207341 Methods for determining compounds capable of inhibiting the activities of the Ha-ras oncogene
11/06/2003US20030207339 PCAM-1 marker protein, nucleic acid sequences encoding PCAM-1 and immunoassays for detection of PCAM-1
11/06/2003US20030207330 Fibrinogen binding moieties
11/06/2003US20030207325 Methods for identifying agents which alter histone protein acetylation, decrease aging, increase lifespan
11/06/2003US20030207324 Immunotherapy by modulation of antigen presentation
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207316 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
11/06/2003US20030207315 Anti-aging nucleic acid and protein targets
11/06/2003US20030207309 Diagnostics and therapeutics for macular degeneration-related disorders
11/06/2003US20030207301 Assay for the detection of factors that modulate the expression of INGAP
11/06/2003US20030207291 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
11/06/2003US20030207288 G-protein coupled receptor (GPCR)-like retinoid acid induced molecule differentially expressed in an animal model; Compositions and methods pertaining to treatment and diagnosis of metabolic disorders, such as diabetes, obesity
11/06/2003US20030207285 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing prognosing disorders related to the polypeptides
11/06/2003US20030207263 Method of screening therapeutic agents
11/06/2003US20030207262 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/06/2003US20030207252 Treatment and diagnostic drugs, kits
11/06/2003US20030207251 For drug screening
11/06/2003US20030206970 Ophthalmic compositions containing galactomannan polymers and borate
11/06/2003US20030206963 Bone resorption suppressing agent
11/06/2003US20030206962 Administering Product R to maintain and improve production of white blood cells and platelets and to reduce gastrointestinal toxicity
11/06/2003US20030206957 Orally administered medicament delivery systems
11/06/2003US20030206956 Topical treatment of prevention of ocular infections
11/06/2003US20030206949 Dispersible phospholipid stabilized microparticles
11/06/2003US20030206946 Methods for therapy of connective tissue disease
11/06/2003US20030206945 Sticking plaster for controlled release of natural interferon
11/06/2003US20030206942 Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
11/06/2003US20030206941 Fast dissolving orally consumable films
11/06/2003US20030206939 Treating and/or preventing dental caries and/or tooth erosion, dental sensitivity, mouth odor, osteoporosis, calculus formation or gingivitis; recrystallising and/or remineralising enamel and/or dentine; buffering plaque
11/06/2003US20030206938 Also bactericidal or bacteriostatic contact lens coated with the peptide
11/06/2003US20030206937 Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects
11/06/2003US20030206930 Soft gelatin capsule manufacture
11/06/2003US20030206923 Combination of soybean, mushroom and mung bean provides phytoestrogens, beta-glucans, saponins, inositol hexaphosphate, and lectins.
11/06/2003US20030206921 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/06/2003US20030206919 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
11/06/2003US20030206918 Compositions and methods for the therapy and diagnosis of ovarian cancer
11/06/2003US20030206915 Extracellular proteins
11/06/2003US20030206911 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target
11/06/2003US20030206910 Poloxamer 188, Poloxamer 237, Poloxamer 338, Poloxamer 124, Poloxamer 401, Tetronic 904, Tetronic 908, Tetronic 1107 or Tetronic 90R4; especially for treating chronic hepatitis and cancer
11/06/2003US20030206908 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
11/06/2003US20030206906 Water, a plasminogen activator, and a bacteriostatic organic alcohol preservative; does not contain a chelating agent; removal of fibrin-bound blood clots from a catheter
11/06/2003US20030206904 Method and therapeutic compositions for the treatment of myocardial infarction
11/06/2003US20030206903 Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody
11/06/2003US20030206902 Administering an antagonist of a vascular endothelial cadherin; and administering an antagonist of a vascular endothelial growth factor receptor.
11/06/2003US20030206900 Vectors derived from antibodies for transferring substances into cells
11/06/2003US20030206899 Vascular endothelial cell growth factor antagonists
11/06/2003US20030206897 Oil in water emulsion useful for treating skin or hair comprising: subtilisin protease enzyme; and a polyhydric alcohol
11/06/2003US20030206892 Methods of modulating activity of DXR
11/06/2003US20030206890 Insect cells utilized that may be transformed with an expression system and thus proteins may be introduced into the composition through direct protein expression by the cells.
11/06/2003US20030206889 Methods of treating anemia using recombinant adeno-associated virus virions
11/06/2003US20030206887 RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)
11/06/2003US20030206885 Vaccine immunotherapy for immune suppressed patients
11/06/2003US20030206875 Compositions for treating biofilm
11/06/2003US20030206859 Nanometer-sized carrier medium
11/06/2003US20030205409 Apparatus and method for maintaining control of a drilling machine
11/06/2003US20030205229 Drug delivery apparatus
11/06/2003CA2711709A1 Oral care compositions containing ovomucin
11/06/2003CA2484453A1 Medicinal compositions containing photocrosslinkable chitosan derivative
11/06/2003CA2484306A1 Prophylactic and therapeutic agent of diabetes mellitus
11/06/2003CA2484223A1 Use of human neural stem cells secreting gdnf for treatment of parkinson's and other neurodegenerative diseases
11/06/2003CA2484089A1 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
11/06/2003CA2483980A1 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands
11/06/2003CA2483635A1 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head
11/06/2003CA2483557A1 Methods and compositions for treating, preventing or delaying onset of a neoplasm
11/06/2003CA2483554A1 Treatment of hypertension in women receiving hormone replacement therapy
11/06/2003CA2483505A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003CA2483449A1 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
11/06/2003CA2483441A1 Mannose binding lectin and uses thereof
11/06/2003CA2483431A1 Alternatively spliced nucleic acid molecules
11/06/2003CA2483336A1 Method and apparatus for ultrasound treatment of connective tissue
11/06/2003CA2483323A1 Contraceptive targets
11/06/2003CA2483270A1 Treatment of alpha-galactosidase a deficiency
11/06/2003CA2483265A1 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/06/2003CA2483106A1 Decoys for treating and/or preventing th2 cytokine-related allergic diseases, gata3 mutant proteins and, pharmaceutical compositions comprising the decoys and the proteins
11/06/2003CA2483102A1 Treatment and prevention of pulmonary conditions
11/06/2003CA2483007A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003CA2483005A1 Treatment of metabolic syndrome
11/06/2003CA2482996A1 Vitamin d3 upregulated protein 1 treats post-infarct myocardial ischemia
11/06/2003CA2482932A1 Colloidal suspension of submicronic particles for delivering active principles and method for preparing same
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
11/06/2003CA2480291A1 Adipocyte complement related protein zacrp14
11/05/2003EP1359222A2 Hybrid human/porcine factor VIII
11/05/2003EP1359221A2 HIV antisense proteins
11/05/2003EP1359218A1 Rna showing neuron survival activity
11/05/2003EP1359159A2 Analogues of GLP-1
11/05/2003EP1359157A1 Metallo-proteinase inhibitory agent
11/05/2003EP1358888A1 The human peptide antibiotic LL-37/hCAP-18 is an inducer of angiogenesis
11/05/2003EP1358874A1 Peptide/lipid complex formation by co-lyopholization
1 ... 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 ... 3163